Comparison of the prognostic value of four methods to assess mitotic activity in 186 invasive breast cancer patients: Classical and random mitotic activity assessments with correction for volume percentage of epithelium
- 1 October 1995
- journal article
- research article
- Published by Elsevier in Human Pathology
- Vol. 26 (10) , 1086-1092
- https://doi.org/10.1016/0046-8177(95)90270-8
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- The morphometric prognostic index is the strongest prognosticator in premenopausal lymph node-negative and lymph node-positive breast cancer patientsHuman Pathology, 1991
- Further evaluation of the prognostic value of morphometric and flow cytometric parameters in breast‐cancer patients with long follow‐upInternational Journal of Cancer, 1990
- The multivariate prognostic index and nuclear DNA content are independent prognostic factors in primary breast cancer patientsCytometry, 1989
- Comparison of extent of disease and morphometric and DNA flow cytometric prognostic factors in invasive ductal breast cancer.Journal of Clinical Pathology, 1987
- Prospective evaluation of prognostic value of morphometry in patients with primary breast cancer.Journal of Clinical Pathology, 1987
- Mitosis counts:Human Pathology, 1986
- The value of morphometry to classic prognosticators in breast cancerCancer, 1985
- Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancerBreast Cancer Research and Treatment, 1985
- ADJUVANT CMF CHEMOTHERAPY IN OPERABLE BREAST CANCER: TEN YEARS LATERThe Lancet, 1985
- Prognostic indicators in breast cancer‐morphometric methodsHistopathology, 1982